Navigation Links
Endo Pharmaceuticals Announces Proposal to Change Name of Parent Company and Rebrands Enterprise: Revealing an Innovative Corporate Structure Dedicated to Redefining Healthcare Value
Date:3/1/2012

CHADDS FORD, Pa., March 1, 2012 /PRNewswire/ -- Endo (Nasdaq: ENDP), a diversified healthcare solutions company, today announced the aggregation of its operating companies as part of an enterprise-wide branding initiative.  The integration of its diversified operating companies and the introduction of its new corporate identity reflect the company's significant transformation as a result of a series of recent strategic acquisitions and business development decisions.

In connection with this initiative, Endo Pharmaceuticals Holdings Inc., the parent company, will ask its shareholders to approve changing its name to Endo Health Solutions Inc. at its annual meeting of shareholders in May 2012.

With a uniquely diversified foundation of complementary healthcare businesses within well-defined therapeutic areas, the new Endo is structured to provide integrated, end-to-end solutions in pain management and urology. The vision is to approach therapeutic areas and disease states as pathways, and to identify, develop and incorporate medical interventions beyond the traditional chemical and biological treatments.

The company will deliver various products and services through its four operating companies: AMS, a developer of innovative medical devices; Endo Pharmaceuticals, a provider of branded pharmaceuticals; HealthTronics, a provider of medical services, practice management software, laboratory solutions and EHR technology; and Qualitest, a manufacturer of high-quality generic pharmaceuticals.

"With the right organizations in place, we have modernized our four distinct operating companies into one enterprise that reflects a powerful combination of compatible organizations aimed at delivering fully integrated healthcare solutions for the benefit of physicians, payers and patients," said Dave Holveck, President and CEO of Endo.  "We are excited to
'/>"/>

SOURCE Endo Pharmaceuticals Holdings Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... Zimmer Holdings, Inc. (NYSE and SIX: ZMH) ... buyers to divest in the United States ... Biomet Discovery® Elbow System assets and Cobalt™ bone cement ... pending acquisition of Biomet, Inc. ("Biomet").  , ... with the Bureau of Competition Staff of the U.S. ...
(Date:5/28/2015)... NEW YORK , May 28, 2015 ... billions developing new drugs and tests, and ... for the instruments that can assist them. This ... research publisher. Kalorama Information said instruments such as ... can assist in the identification of drug ...
(Date:5/28/2015)... 28, 2015  Maetrics ( http://maetrics.com ), a leading ... wrapped up a successful conference, "The cost of non-compliance -- ... today in Zurich . ... its Switzerland -based team, experts provided ... Technology field to an exclusive local audience. The event ...
Breaking Medicine Technology:Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 2Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 3Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 4Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 5Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 6Report: Proteomics Research Market Reaches $1.6 Billion 2Report: Proteomics Research Market Reaches $1.6 Billion 3Maetrics Hosts Innovative Medical Cluster Event in Switzerland 2
(Date:5/28/2015)... 2015 The Clinical Data Interchange ... the International Organization for Standardization (ISO) now recognizes ... Model version 3.2 as a published, Final International ... healthcare. This standard, which had previously passed through ... unanimously approved on 24 April for publication by ...
(Date:5/28/2015)... The Boys & Girls Club of Atlantic ... Cross Blue Shield of New Jersey (Horizon BCBSNJ) and through ... can receive much more support as play begins for the ... Boys & Girls Club member and volunteer with the organization ... has accepted the Horizon Blue Cross Blue Shield of New ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 Are policies ... after a hospital stay triggering financial pain for seniors? ... American Journal of Managed Care set to figure out, ... recent federal rule change. , The study, “Observation Encounters ... A. Vashi, MD, MPH, examined how Medicare policies that ...
(Date:5/28/2015)... ISMETT , a leading transplant hospital ... Sicilian economy by €132.5 million in expenditure in 2013, generated ... than €73 million by retaining patients who otherwise would have ... study by the Battelle Memorial Institute. At the same time, ... advanced health care management that is transforming Sicily into a ...
(Date:5/28/2015)... 2015 Workers’ compensation costs per claim in ... recent study by the Workers Compensation Research Institute ... period. , The WCRI study, CompScope™ Benchmarks for Michigan, ... seven days or more of work with those of 16 ... Michigan claim was 4 percent lower than similar claims from ...
Breaking Medicine News(10 mins):Health News:CDISC Announces BRIDG Model for Research as Final ISO Standard 2Health News:CDISC Announces BRIDG Model for Research as Final ISO Standard 3Health News:Golf Pro Natalie Gulbis to Chip in with Horizon Blue Cross Blue Shield of New Jersey to Support Boys & Girls Club of Atlantic City 2Health News:Golf Pro Natalie Gulbis to Chip in with Horizon Blue Cross Blue Shield of New Jersey to Support Boys & Girls Club of Atlantic City 3Health News:AJMC Study Examines Effect of Medicare Rules on Care After Hospital Observation 2Health News:AJMC Study Examines Effect of Medicare Rules on Care After Hospital Observation 3Health News:UPMC-Managed Transplant Hospital Drives Major Economic Benefits for Sicily, Study Finds 2Health News:UPMC-Managed Transplant Hospital Drives Major Economic Benefits for Sicily, Study Finds 3Health News:Michigan Workers’ Compensation Costs Lower Than Most States, Says WCRI Study 2
... , , HARRISBURG, Pa., July ... received free dental care, valued at nearly $160,000, in the ... United Concordia Dental. , , ... provide free preventive services to those who cannot afford dental ...
... , INDIANAPOLIS, July 23 Today, ... that the U.S. Food and Drug Administration (FDA) has approved ... origin) injection] to treat osteoporosis associated with sustained, systemic glucocorticoid ... Glucocorticoid therapy is the most common cause of secondary osteoporosis, ...
... Cancer stem-like cells have been implicated in the ... at Cedars-Sinai Medical Center,s Maxine Dunitz Neurosurgical Institute have ... these "mother" cells to generate new tumors in laboratory ... a possible strategy in the fight against malignant and ...
... , , , , ... Program (NCDP), a program of Novo Nordisk, and several member associations today ... and treatment of diabetes, one of the nation,s most pervasive and costly ... , In an open letter to the President and ...
... , , SAN DIEGO, ... ) today announced that it has priced an underwritten public ... price of $7.50 per share. Net proceeds, after estimated underwriting ... million. Orexigen has granted the underwriter a 30-day option to ...
... 23 At the 2009 American Association of Physicists ... California, Elekta will demonstrate how the company,s comprehensive VMAT ... care with precision and ease. , , ... radiation treatments, Elekta booth 423 will highlight treatment planning ...
Cached Medicine News:Health News:More than 1,000 Underinsured and Uninsured Individuals Receive Free Dental Care 2Health News:FDA Approves Expanded Use of Lilly's FORTEO(R) [teriparatide (rDNA origin) injection] to Treat Glucocorticoid-Induced Osteoporosis 2Health News:FDA Approves Expanded Use of Lilly's FORTEO(R) [teriparatide (rDNA origin) injection] to Treat Glucocorticoid-Induced Osteoporosis 3Health News:FDA Approves Expanded Use of Lilly's FORTEO(R) [teriparatide (rDNA origin) injection] to Treat Glucocorticoid-Induced Osteoporosis 4Health News:FDA Approves Expanded Use of Lilly's FORTEO(R) [teriparatide (rDNA origin) injection] to Treat Glucocorticoid-Induced Osteoporosis 5Health News:FDA Approves Expanded Use of Lilly's FORTEO(R) [teriparatide (rDNA origin) injection] to Treat Glucocorticoid-Induced Osteoporosis 6Health News:Study provides documentation that tumor 'stem-like cells' exist in benign tumors 2Health News:Study provides documentation that tumor 'stem-like cells' exist in benign tumors 3Health News:NCDP Health Care Reform Recommendations Advocate for Diabetes Prevention, Treatment and Care 2Health News:NCDP Health Care Reform Recommendations Advocate for Diabetes Prevention, Treatment and Care 3Health News:Orexigen(R) Therapeutics Prices Public Offering of Common Stock 2Health News:Comprehensive VMAT Solution From Elekta on Center Stage at 2009 AAPM Annual Meeting 2Health News:Comprehensive VMAT Solution From Elekta on Center Stage at 2009 AAPM Annual Meeting 3
Reusable shielded cable...
... A OIA MAX test delivers excellent sensitivity ... Strep with a simple, easy-to-use test that ... of performance, speed, and ease-of-use enables you ... overall costs for diagnosing and treating patients ...
The GC OIA test is a rapid assay for the diagnosis of gonorrhea. Thermo solved the challenge of developing a specific rapid assay for Neisseria gonorrhea by using the proprietary ribosomal protein, ...
... The FLU OIA test is a ... diagnosis of Influenza A and B with ... answer in just over 15 minutes. Assay ... specimen flexibility, and performance equivalent to 14-day ...
Medicine Products: